Molecular Diagnostics in China is a Billion dollar business and it’s growing every year. Colorectal Cancer Test and Virology Test together accounts for 70% market share. Breast Cancer test is also a very important figure in China Molecular Diagnostics field. With 1.1 Million new cases every year, Breast cancer is the primary reason of death among women in China. In the last 30 years China’s breast cancer mortality has doubled. This happens mostly because diagnosis is done at later stage III/IV or when women is older. However in comparison to western countries patients are diagnosed earlier and they have higher recovery rate.
Although screening programs for breast cancer are almost available in all the provinces of China, but its coverage is highly inconsistent. China do not have any systematized screening program, screening of Chinese women is on voluntarily basis or they look for medical help when any abnormality is detected.
1. Executive Summary
2. China Molecular Diagnostic Market & Test Volume Forecast
2.1 China Molecular Diagnostic Market (2010 – 2019)
2.2 China Molecular Diagnostic Test Volume (2010 – 2019)
3. China Molecular Diagnostic Market & Test Volume Share Analysis
3.1 China Molecular Diagnostic Market Share (2010 – 2019)
3.2 China Molecular Diagnostic Application Market Share (2010 – 2019)
3.3 China Molecular Diagnostic Test Volume Share (2010 – 2019)
3.4 China Molecular Diagnostic Test Volume Application Share (2010 – 2019)
5. China Molecular Diagnostic Market & Forecast – Application Wise (2010 – 2019)
5.1 China Molecular Oncology Test Market & Volume Share (2010 – 2019)
5.2 Oncology Testing Market & Volume (2010 – 2019)
5.2.1 Breast Cancer Testing Market & Volume (2010 – 2019)
5.2.2 Colorectal Cancer Testing Market & Volume (2010 – 2019)
5.2.3 Prostate Cancer Testing Market & Volume (2010 – 2019)
5.3 China Molecular Infectious Disease Test Market & Volume Share (2010 – 2019)
5.4 Infectious Disease Testing Market & Volume (2010 – 2019)
5.4.1 Virology Testing Market & Volume (2010 – 2019)
5.4.2 HPV Testing Market & Volume (2010 – 2019)
5.5 China Molecular Genetic Test Market & Volume Share (2010 – 2019)
5.6 Genetic Testing Market & Volume (2010 – 2019)
5.6.1 Blood Screening Market & Volume (2010 – 2019)
5.6.2 HLA Testing Market & Volume (2010 – 2019)
6. Growth Drivers
8. Profiles of Select Private Clinical Labs and Diagnostic Services Companies
Click here to view the report details: http://www.renub.com/china-molecular-diagnostics-market-test-volume-and-forecast-491-p.php
For more information:
Sales & Marketing Div
Phone: +1-678-302-0700 (USA), +91-120-421-9822, +91-120-424-9780 (India)
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.